Safety Profile of a Multi-Antigenic DNA Vaccine Against Hepatitis C Virus

Despite direct acting antivirals (DAAs) curing >95% of individuals infected with hepatitis C (HCV), in order to achieve the World Health Organization HCV Global Elimination Goals by 2030 there are still major challenges that need to be overcome. DAAs alone are unlikely to eliminate HCV in the abs...

Full description

Saved in:
Bibliographic Details
Published in:Vaccines (Basel)
Main Authors: Gummow, Jason, Masavuli, Makutiro G., Mekonnen, Zelalem A., Li, Yanrui, Wijesundara, Danushka K., Shrestha, Ashish C., Voskoboinik, Ilia, Gowans, Eric J., Grubor-Bauk, Branka
Format: Artigo
Language:Inglês
Published: MDPI 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7158683/
https://ncbi.nlm.nih.gov/pubmed/32013228
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8010053
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items